These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 23711954)
1. Second-trimester screening for trisomy-21 using prefrontal space ratio. Chaveeva P; Agathokleous M; Poon LC; Markova D; Nicolaides KH Fetal Diagn Ther; 2013; 34(1):50-5. PubMed ID: 23711954 [TBL] [Abstract][Full Text] [Related]
2. Prefrontal space ratio in second- and third-trimester screening for trisomy 21. Yazdi B; Sonek J; Oettling C; Hoopmann M; Abele H; Schaelike M; Kagan KO Ultrasound Obstet Gynecol; 2013 Mar; 41(3):262-6. PubMed ID: 22791586 [TBL] [Abstract][Full Text] [Related]
3. Prefrontal space ratio: comparison between trisomy 21 and euploid fetuses in the second trimester. Sonek J; Molina F; Hiett AK; Glover M; McKenna D; Nicolaides KH Ultrasound Obstet Gynecol; 2012 Sep; 40(3):293-6. PubMed ID: 22302766 [TBL] [Abstract][Full Text] [Related]
4. Nasal bone length, prenasal thickness, prenasal thickness-to-nasal bone length ratio and prefrontal space ratio in second- and third-trimester fetuses with Down syndrome. Vos FI; De Jong-Pleij EA; Bakker M; Tromp E; Pajkrt E; Kagan KO; Bilardo CM Ultrasound Obstet Gynecol; 2015 Feb; 45(2):211-6. PubMed ID: 24753093 [TBL] [Abstract][Full Text] [Related]
5. Sphenofrontal distance in euploid and aneuploid fetuses. Abele H; Sonek J; Goldschmid D; Wagner P; Hoopmann M; Kagan KO Ultrasound Obstet Gynecol; 2017 Aug; 50(2):187-191. PubMed ID: 27550089 [TBL] [Abstract][Full Text] [Related]
6. Facial profile markers in second- and third-trimester fetuses with trisomy 18. Vos FI; de Jong-Pleij EA; Bakker M; Tromp E; Manten GT; Bilardo CM Ultrasound Obstet Gynecol; 2015 Jul; 46(1):66-72. PubMed ID: 25196037 [TBL] [Abstract][Full Text] [Related]
7. Measurement of inferior facial angle and prefrontal space ratio in first trimester fetuses with aneuploidies: a retrospective study. Tekesin I; Graupner O J Perinat Med; 2019 Nov; 47(9):969-978. PubMed ID: 31622251 [TBL] [Abstract][Full Text] [Related]
8. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks. Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854 [TBL] [Abstract][Full Text] [Related]
9. The cavum septi pellucidi in euploid and aneuploid fetuses. Abele H; Babiy-Pachomow O; Sonek J; Hoopmann M; Schaelike M; Kagan KO Ultrasound Obstet Gynecol; 2013 Aug; 42(2):156-60. PubMed ID: 23303556 [TBL] [Abstract][Full Text] [Related]
11. Facial markers in second- and third-trimester fetuses with trisomy 18 or 13, triploidy or Turner syndrome. Kagan KO; Sonek J; Berg X; Berg C; Mallmann M; Abele H; Hoopmann M; Geipel A Ultrasound Obstet Gynecol; 2015 Jul; 46(1):60-5. PubMed ID: 25175793 [TBL] [Abstract][Full Text] [Related]
12. Frontomaxillary facial angles in screening for trisomy 21 at 14-23 weeks' gestation. Sonek J; Borenstein M; Downing C; McKenna D; Neiger R; Croom C; Genrich T; Nicolaides KH Am J Obstet Gynecol; 2007 Aug; 197(2):160.e1-5. PubMed ID: 17689634 [TBL] [Abstract][Full Text] [Related]
13. Maxillary length at 11-14 weeks of gestation in fetuses with trisomy 21. Cicero S; Curcio P; Rembouskos G; Sonek J; Nicolaides KH Ultrasound Obstet Gynecol; 2004 Jul; 24(1):19-22. PubMed ID: 15229911 [TBL] [Abstract][Full Text] [Related]
14. First-trimester combined screening for trisomy 21 with different combinations of placental growth factor, free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Kagan KO; Hoopmann M; Abele H; Alkier R; Lüthgens K Ultrasound Obstet Gynecol; 2012 Nov; 40(5):530-5. PubMed ID: 22611005 [TBL] [Abstract][Full Text] [Related]
15. Femur length and trisomy 21: impact of gestational age on screening efficiency. Snijders RJ; Platt LD; Greene N; Carlson D; Krakow D; Gregory K; Bradley K Ultrasound Obstet Gynecol; 2000 Aug; 16(2):142-5. PubMed ID: 11117083 [TBL] [Abstract][Full Text] [Related]
16. Assessment of the ductus venosus, tricuspid blood flow and the nasal bone in second-trimester screening for trisomy 21. Stressig R; Kozlowski P; Froehlich S; Siegmann HJ; Hammer R; Blumenstock G; Kagan KO Ultrasound Obstet Gynecol; 2011 Apr; 37(4):444-9. PubMed ID: 20645398 [TBL] [Abstract][Full Text] [Related]
17. Sequential screening for trisomy 21 by nuchal translucency measurement in the first trimester and maternal serum biochemistry in the second trimester in a low-risk population. Schuchter K; Hafner E; Stangl G; Ogris E; Philipp K Ultrasound Obstet Gynecol; 2001 Jul; 18(1):23-5. PubMed ID: 11489220 [TBL] [Abstract][Full Text] [Related]
18. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11-13 weeks of gestation. Maiz N; Valencia C; Kagan KO; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2009 May; 33(5):512-7. PubMed ID: 19338027 [TBL] [Abstract][Full Text] [Related]
19. Three-dimensional evaluation of mid-facial hypoplasia in fetuses with trisomy 21 at 11 + 0 to 13 + 6 weeks of gestation. Dagklis T; Borenstein M; Peralta CF; Faro C; Nicolaides KH Ultrasound Obstet Gynecol; 2006 Sep; 28(3):261-5. PubMed ID: 16865677 [TBL] [Abstract][Full Text] [Related]
20. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Nicolaides KH; Spencer K; Avgidou K; Faiola S; Falcon O Ultrasound Obstet Gynecol; 2005 Mar; 25(3):221-6. PubMed ID: 15736186 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]